Logo image
Response to a Case of Travel-Associated Lassa Fever - Iowa, October-November 2024
Journal article

Response to a Case of Travel-Associated Lassa Fever - Iowa, October-November 2024

Diana L. Von Stein, Alexandra Barger, Andrew Hennenfent, Robert Ramaekers, Amanda Mandi, Karen Brust, Jonathan Simmons, Nicholas Mohr, Lisa Veach, Sudhir Kumar, …
MMWR. Morbidity and mortality weekly report, Vol.74(11), pp.194-196
04/03/2025
DOI: 10.15585/mmwr.mm7411a3
PMCID: PMC11970722
PMID: 40179054

View Online

Abstract

Summary What is already known about this topic? Lassa fever is a viral hemorrhagic fever (VHF) endemic to western Africa. Before 2024, eight travel-associated cases had been identified in the United States. What is added by this report? A fatal Lassa fever case in a patient returning from Liberia, the first U.S. case diagnosed in eight years and the ninth U.S. travel-associated case since 1969, was identified in Iowa in late 2024. Investigation identified 180 contacts. Lassa fever virus testing was performed for five symptomatic contacts; all laboratory results were negative. What are the implications for public health practice? The coordinated public health response to this case underscores the importance of eliciting a travel history from febrile patients, effective VHF planning within public health departments and medical communities, and the importance of rapid local testing capabilities.
Life Sciences & Biomedicine Public, Environmental & Occupational Health Science & Technology

Details

Logo image